CTIS2023-509210-10-00进行中（未招募）1 期
NL85300.041.23
niversitair Medisch Centrum Utrecht0 个研究点目标入组 24 人开始时间: 2023年11月10日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A study in healthy men to test whether itraconazole influences the amount of BI 1584862 in the bloodHealthy volunteer trialMedDRA version: 21.0Level: LLTClassification code: 10053349Term: Pharmacokinetic study Class: 10022891CTIS2023-503542-31-00Boehringer Ingelheim International GmbH14
招募中
1 期
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimabhead and neck squamous cell carcinoma, non-small cell lung cancer or, melanomaCTIS2024-514034-20-00Boehringer Ingelheim International GmbH13
招募中
1 期
A Study of NB003 in Patients With Advanced MalignanciesCTIS2022-502401-15-00ingbo Newbay Technology Development Co. Ltd.290
进行中（未招募）
1 期
A randomised, open-label, reference-replicated crossover trial to investigate the bioequivalence of two formulations of Silexan 80 mg in healthy volunteersCTIS2023-503647-34-00Dr. Willmar Schwabe GmbH & Co. KG92
招募中
1 期
Investigation of safety, tolerability and pharmacokinetics of multiple doses of NNC0113-6856 in healthy participants, including a subset of healthy Japanese participantsType 2 diabetesMedDRA version: 21.1Level: LLTClassification code: 10045242Term: Type II diabetes mellitus Class: 10027433CTIS2023-503891-26-00ovo Nordisk A/S170